Antimicrobial Resistance in the COVID-19 Landscape: Is There an Opportunity for Anti-Infective Antibodies and Antimicrobial Peptides?

Abstract

Although COVID-19 has captured most of the public health attention, antimicrobial resistance (AMR) has not disappeared. To prevent the escape of resistant microorganisms in animals or environmental reservoirs a “one health approach” is desirable. In this context of COVID-19, AMR has probably been affected by the inappropriate or over-use of antibiotics. The increased use of antimicrobials and biocides for disinfection may have enhanced the prevalence of AMR. Antibiotics have been used empirically in patients with COVID-19 to avoid or prevent bacterial coinfection or superinfections. On the other hand, the measures to prevent the transmission of COVID-19 could have reduced the risk of the emergence of multidrug-resistant microorganisms. Since we do not currently have a sterilizing vaccine against SARS-CoV-2, the virus may still multiply in the organism and new mutations may occur. As a consequence, there is a risk of the appearance of new variants. Nature-derived anti-infective agents, such as antibodies and antimicrobial peptides (AMPs), are very promising in the fight against infectious diseases, because they are less likely to develop resistance, even though further investigation is still required.

Nano‐biotechnology in tumour and cancerous disease: A perspective review

“…It can develop either spontaneously or as a result of other factors. After an intensive surgical procedure, such as treatment for endometrial cancer, a patient may become colonized with various types of bacteria, and may need to stay in the hospital longer 221 . It is possible that the usage of antimicrobial bandages might improve several wound healing factors 222,223 …”

Evaluation of pre-treated healthcare wastes during COVID-19 pandemic reveals pathogenic microbiota, antibiotics residues, and antibiotic resistance genes against beta-lactams

“…Antimicrobial resistance (AMR) represents a global threat where microbial pathogens continue to evolve and develop resistance to existing antibiotics, putting the world in another pandemic ( Aljeldah, 2022 ). The extensive use of antibiotics in the treatment of bacterial infections in COVID-19 patients enhanced the prevalence of AMR, which might result in clinical complications and the development of multidrug-resistant microorganisms ( Pérez de la Lastra et al, 2022 ).…”

Environmental challenges of COVID-19 pandemic: resilience and sustainability – A review

“…In this frame, it has also emerged that not only toxicity but also antimicrobial resistance is a very dangerous effect caused by excessive chemical use ( Singh, 2020 ). In particular, due to the biocidal characteristics of disinfectants, their excessive use is associated with an increase in antimicrobial resistance ( Pérez de la Lastra et al, 2022 ). It is reported that exposure to 0.0004% phenolic disinfectant triclosan increases the risk to develop bacterial resistance and cross-resistance in Staphylococcus aureus and Escherichia coli ( Wesgate et al, 2016 ).…”